rs2231137

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_004827.3(ABCG2):​c.34G>A​(p.Val12Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0615 in 1,613,912 control chromosomes in the GnomAD database, including 6,281 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign,Affects,association (no stars).

Frequency

Genomes: 𝑓 0.078 ( 846 hom., cov: 33)
Exomes 𝑓: 0.060 ( 5435 hom. )

Consequence

ABCG2
NM_004827.3 missense

Scores

18

Clinical Significance

Likely benign; Affects; association no assertion criteria provided B:1O:2

Conservation

PhyloP100: 0.210

Publications

308 publications found
Variant links:
Genes affected
ABCG2 (HGNC:74): (ATP binding cassette subfamily G member 2 (JR blood group)) The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, this protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Significant expression of this protein has been observed in the placenta, which may suggest a potential role for this molecule in placenta tissue. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0050233305).
BP6
Variant 4-88139962-C-T is Benign according to our data. Variant chr4-88139962-C-T is described in ClinVar as Likely_benign|Affects|association. ClinVar VariationId is 30386.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.3 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCG2NM_004827.3 linkc.34G>A p.Val12Met missense_variant Exon 2 of 16 ENST00000237612.8 NP_004818.2 Q9UNQ0-1A1LUE4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCG2ENST00000237612.8 linkc.34G>A p.Val12Met missense_variant Exon 2 of 16 1 NM_004827.3 ENSP00000237612.3 Q9UNQ0-1

Frequencies

GnomAD3 genomes
AF:
0.0782
AC:
11894
AN:
152128
Hom.:
837
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0635
Gnomad AMI
AF:
0.0439
Gnomad AMR
AF:
0.156
Gnomad ASJ
AF:
0.102
Gnomad EAS
AF:
0.313
Gnomad SAS
AF:
0.158
Gnomad FIN
AF:
0.128
Gnomad MID
AF:
0.0759
Gnomad NFE
AF:
0.0371
Gnomad OTH
AF:
0.0979
GnomAD2 exomes
AF:
0.114
AC:
28639
AN:
250804
AF XY:
0.109
show subpopulations
Gnomad AFR exome
AF:
0.0660
Gnomad AMR exome
AF:
0.238
Gnomad ASJ exome
AF:
0.107
Gnomad EAS exome
AF:
0.326
Gnomad FIN exome
AF:
0.127
Gnomad NFE exome
AF:
0.0408
Gnomad OTH exome
AF:
0.104
GnomAD4 exome
AF:
0.0598
AC:
87391
AN:
1461666
Hom.:
5435
Cov.:
31
AF XY:
0.0618
AC XY:
44971
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.0638
AC:
2135
AN:
33476
American (AMR)
AF:
0.229
AC:
10228
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.105
AC:
2744
AN:
26126
East Asian (EAS)
AF:
0.265
AC:
10536
AN:
39694
South Asian (SAS)
AF:
0.140
AC:
12048
AN:
86234
European-Finnish (FIN)
AF:
0.124
AC:
6594
AN:
53370
Middle Eastern (MID)
AF:
0.102
AC:
588
AN:
5768
European-Non Finnish (NFE)
AF:
0.0339
AC:
37733
AN:
1111930
Other (OTH)
AF:
0.0792
AC:
4785
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
4125
8249
12374
16498
20623
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1754
3508
5262
7016
8770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0783
AC:
11926
AN:
152246
Hom.:
846
Cov.:
33
AF XY:
0.0867
AC XY:
6452
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0638
AC:
2650
AN:
41536
American (AMR)
AF:
0.156
AC:
2382
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.102
AC:
355
AN:
3472
East Asian (EAS)
AF:
0.312
AC:
1616
AN:
5176
South Asian (SAS)
AF:
0.157
AC:
757
AN:
4822
European-Finnish (FIN)
AF:
0.128
AC:
1354
AN:
10596
Middle Eastern (MID)
AF:
0.0782
AC:
23
AN:
294
European-Non Finnish (NFE)
AF:
0.0371
AC:
2523
AN:
68034
Other (OTH)
AF:
0.107
AC:
226
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
520
1041
1561
2082
2602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0588
Hom.:
1164
Bravo
AF:
0.0829
TwinsUK
AF:
0.0332
AC:
123
ALSPAC
AF:
0.0340
AC:
131
ESP6500AA
AF:
0.0606
AC:
267
ESP6500EA
AF:
0.0378
AC:
325
ExAC
AF:
0.106
AC:
12868
Asia WGS
AF:
0.254
AC:
882
AN:
3478
EpiCase
AF:
0.0453
EpiControl
AF:
0.0469

ClinVar

Significance: Likely benign; Affects; association
Submissions summary: Benign:1Other:2
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

ABCG2-related disorder Benign:1
Jul 21, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1 Other:1
Jan 15, 2012
OMIM
Significance:association
Review Status:no assertion criteria provided
Collection Method:literature only

- -

BLOOD GROUP, JUNIOR SYSTEM Other:1
Jan 15, 2012
OMIM
Significance:Affects
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
1.6
DANN
Benign
0.054
DEOGEN2
Benign
0.041
.;T;T;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.00089
N
LIST_S2
Benign
0.21
T;T;.;T
MetaRNN
Benign
0.0050
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.9
N;N;.;.
PhyloP100
0.21
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.69
N;N;N;.
REVEL
Benign
0.18
Sift
Benign
1.0
T;T;D;.
Sift4G
Benign
1.0
T;T;.;.
Polyphen
0.0070
B;B;.;.
Vest4
0.075
MPC
0.030
ClinPred
0.00058
T
GERP RS
1.5
Varity_R
0.021
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2231137; hg19: chr4-89061114; COSMIC: COSV52945187; API